Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2000
10/26/2000CA2369820A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2368029A1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2365497A1 Compound assay using nematodes
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046711A2 Recombinant adeno-associated virus
10/25/2000EP1046710A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046402A1 Aged skin equivalent, methods of preparation and uses thereof
10/25/2000EP1046400A1 Methods and compositions for treating human cells
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045921A2 Feline immunodeficiency virus gene therapy vectors
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045918A1 G protein-related kinase mutants in essential hypertension
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045913A2 Human protease molecules
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045905A2 Il-17rh dna and polypeptides
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045902A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
10/25/2000EP1045899A2 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
10/25/2000EP1045897A1 Enzyme catalyzed therapeutic agents
10/25/2000EP1045857A1 MULTIPLE DRUG RESISTANCE GENE atrC OF ASPERGILLUS NIDULANS
10/25/2000EP1045704A1 Methods for quenching pathogen inactivators in biological materials
10/25/2000EP1045703A1 Stabilization of lipid:dna formulations during nebulization
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP1045637A1 Decorated red blood cells
10/25/2000EP1045635A1 Cloning using donor nuclei from differentiated fetal and adult cells
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0627911B1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/24/2000US6137801 Telecommunication switching system administrative and management tools
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136600 Method for cultivation of hepatocytes
10/24/2000US6136599 Human hybrid host cell for mammalian gene expression
10/24/2000US6136598 Mus dunni endogenous retroviral packaging cell lines
10/24/2000US6136597 Nucleotide sequences comprising regulatory sequences for the efficient transferring of nucleic acid sequences to cytoplasm and expression of heterologous nucleic acids
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136579 Isolating enzymatic protein; infecting a cell culture with pox viral vector, recovering enzymatic protein from lysis products
10/24/2000US6136574 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136570 Method for producing RNA viruses from cDNA
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136562 Synthetic dna which encodes a peptide having a defined amino acid sequence; for recombinant production of the peptide for use in cattle; veterinary medicine
10/24/2000US6136544 Amino acid sequence of unedited form of human excitatory amino acid 4 receptor subunit; for drug screening
10/24/2000US6136538 Silent inducible virus replicons and uses thereof
10/24/2000US6136536 Recombinant dna sequence from plasmid phtop; for production in chinese hamster ovary cell lines
10/24/2000US6136525 Dispensing hepatocytes into freezing containers, freezing from between minus 50 to minus 90 degrees celsius in control rate freezer using specified program, storing containers in liquid or vapor nitrogen, thawing and removing cryoprotectant
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000US6136306 Treatment of a mammalian patient having a tumor by administering to the patient allogenic donor lymphocytes that have been co-cultured in the presence of the patient-derived lymphocytes under conditions sufficient to alloactivate the
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/19/2000WO2000062062A1 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME
10/19/2000WO2000062034A2 Multistage electromagnetic separator for purifying cells, chemicals and protein structures
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061766A2 Telomerase-specific cancer vaccine
10/19/2000WO2000061765A2 Lipoxygenase proteins and polynucleotides encoding the same
10/19/2000WO2000061764A1 Carotene hydroxylase and method for producing xanthophyll derivatives
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061761A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061749A1 Cellular protein p60 that interacts with herpesvirus regulatory proteins
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061744A1 Novel fetal genes
10/19/2000WO2000061730A1 Glucose dehydrogenase
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061728A2 Human elastase i
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061668A1 Preparing porous hydrogel products
10/19/2000WO2000061637A1 Erythropoietin receptor antibodies
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061626A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
1 ... 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 ... 1827